Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.

Murri-Plesko, M; Hulikova, A; Oosterwijk, E; Scott, A; Zortea, A; Harris, A; Ritter, G; Old, L; Bauer, S; Swietach, P; Renner, C

Journal article

Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.

Abstract:: Carbonic anhydrase IX (CAIX) is a hypoxia-induced, membrane-tethered enzyme that is highly expressed in many cancers. It catalyses the hydration of CO(2) to HCO(3)(-) and H(+), and the reverse dehydration reaction. Recent studies have shown an important role for CAIX in pH regulation and it has been speculated that CAIX may play a role in supporting cancer progression towards more aggressive forms of the disease. Clinical correlative studies in many tumours have shown that high expression is related to poor outcome. In the present study, we have selected antigen-binding antibody fragments (Fab) against human CAIX by phage-display, and tested these for inhibitory potency on CAIX catalytic activity. Inhibition was assessed from the kinetics of the CAIX-catalysed reaction, using assays performed on intact cells over-expressing CAIX, and their CAIX-containing membrane fragments. Inhibition was also assessed in multi-cellular tissue-models (spheroids) from the kinetics of CO(2) venting. We have identified a Fab antibody, labelled MSC8, and its corresponding full-length IgG that inhibited CAIX by up to 57% and 76%, respectively, with half-maximal inhibition at 0.3μg/ml. Incubation of CAIX-expressing cells with MSC8 IgG produced a lasting inhibitory effect. The inhibitory effect was prompt and was also observed in isolated membrane-fragments, suggesting that a direct inhibitory interaction takes place between the antibody and CAIX. The inhibitory effects in spheroids argue for a physiological relevance of the antibody. Biologically-active antibodies against CAIX can be used as selective, high-affinity inhibitors in experimental studies to dissect the role of CAIX and, possibly, therapeutically by targeting a catalytically-active cancer-related protein.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Murri-Plesko, M., Hulikova, A., Oosterwijk, E., Scott, A., Zortea, A., Harris, A., Ritter, G., Old, L., Bauer, S., Swietach, P., & Renner, C. (2011). Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX. European Journal of Pharmacology, 657(1-3), 173–183.

MLA Style

Murri-Plesko, M., et al. “Antibody Inhibiting Enzymatic Activity of Tumour-Associated Carbonic Anhydrase Isoform IX.” European Journal of Pharmacology, vol. 657, no. 1-3, 2011, pp. 173–83.

Chicago Style

Murri-Plesko, M, A Hulikova, E Oosterwijk, A Scott, A Zortea, A Harris, G Ritter, et al. 2011. “Antibody Inhibiting Enzymatic Activity of Tumour-Associated Carbonic Anhydrase Isoform IX.” European Journal of Pharmacology 657 (1-3): 173–83.
Share
Print